Table 2 Effect of a-methyl-prednisolone treatment on in vivo and ex vivo pathology signs of mdx mouse
BW (g) | Fmax (kg) | FNmax | EDL sP0 (kN/m2) | EDL rheobase voltage (mV) | % Drop force eccentric contraction | CK (U/l) | |
|---|---|---|---|---|---|---|---|
WT (n=6) | 27,8±0.4 | 0.225±0.007 | 8.1±0.24 | 127.5±12 | −68±1.4 | −0.36±1.43 | 2696±1766 |
MDX+vehicle (n=7) | 25.4±0.97a,b | 0.135±0.005a,b | 5.4±0.3a,b | 87.7±6.0a,b | −75.3±1.4a,b | −8.84±1.84b | 17363±4576a,b |
MDX+PDN (n=9) | 24.4±0.5a,b | 0.159±0.01a,b | 6.6±0.3a,b,c | 108.3±4.8c | −72±1.2a,b,c | −13.17±9.34 | 14807±2441a,b |